Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bárbara Zambiasi Martinelli"'
Autor:
Luise Meurer, Ursula da Silveira Matte, Guilherme Baldo, Bárbara Zambiasi Martinelli, Roberto Giugliani, Fabiana Quoos Mayer, Ricardo Machado Xavier, Patricia Gnieslaw de Oliveira
Publikováno v:
International Journal of Experimental Pathology. 94:305-311
Mucopolysaccharidoses (MPS) are lysosomal storage disorders characterized by mutations in enzymes that degrade glycosaminoglycans (GAGs). Joint disease is present in most forms of MPS, including MPS I. This work aimed to describe the joint disease pr
Autor:
Valeska Lizzi Lagranha, Giuseppe Ávila Testa, Talita Giacomet de Carvalho, Guilherme Baldo, Roberto Giugliani, Ursula da Silveira Matte, Bárbara Zambiasi Martinelli
Publikováno v:
Journal of materials science. Materials in medicine. 28(3)
Mucopolysaccharidosis type I (MPS I) is caused by a deficiency of α-L-iduronidase (IDUA), resulting in accumulation of glycosaminoglycans (GAG) in lysosomes. Microencapsulation of recombinant cells is a promising gene/cell therapy approach that coul
Autor:
Bárbara Zambiasi Martinelli, Ursula da Silveira Matte, Fabiana Quoos Mayer, Fabíola Schons Meyer, Maira Graeff Burin, Angela Maria Vicente Tavares, Roberto Giugliani, Luise Meurer, Guilherme Baldo
Publikováno v:
Cytotherapy. 14:860-867
Mucopolysaccharidosis type I (MPS I) is characterized by deficiency of the enzyme alpha-L-iduronidase (IDUA) and storage of glycosaminoglycans (GAG) in several tissues. Current available treatments present limitations, thus the search for new therapi
Autor:
Gabriela Pasqualim, Angela Maria Vicente Tavares, Ana Paula Krauthein Schneider, Bárbara Zambiasi Martinelli, Fabiana Quoos Mayer, Roberto Giugliani, Ursula da Silveira Matte, Guilherme Baldo, Graziela S. Ribas, Carmen Regla Vargas
Publikováno v:
Translational research : the journal of laboratory and clinical medicine. 176
Temporary interruption of enzyme replacement therapy (ERT) in patients with different lysosomal storage disorders may happen for different reasons (adverse reactions, issues with reimbursement, logistic difficulties, and so forth), and the impact of
Autor:
Guilherme Baldo, Talita Giacomet de Carvalho, Ângela Maria Vicente Tavares, Bárbara Zambiasi Martinelli, Fabíola Schons Meyer, Patricia Gnieslaw de Oliveira, Luise Meurer, Fabiana Quoos Mayer, Ursula da Silveira Matte, Roberto Giugliani
Publikováno v:
Molecular genetics and metabolism. 109(1)
Since we previously observed that in patients with mucopolysaccharidosis (MPS) the storage of undegraded glycosaminoglycans (GAG) occurs from birth, in the present study we aimed to compare normal, untreated MPS I mice (knockout for alpha-l-iduronida
Autor:
Fabiana Quoos Mayer, Fabíola Schons Meyer, Ursula da Silveira Matte, Katherine P. Ponder, Anna Cláudia Dilda, Roberto Giugliani, Guilherme Baldo, Bárbara Zambiasi Martinelli
Mucopolysaccharidosis (MPS) type I (Hurler syndrome) is a lysosomal storage disorder characterized by deficiency of alpha-L-iduronidase (IDUA), intracellular storage of glycosaminoglycans (GAGs) and progressive neurological pathology. The MPS I mouse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3763b8b371d0b8f4d4830f177c94135
https://europepmc.org/articles/PMC3390919/
https://europepmc.org/articles/PMC3390919/
Autor:
Luise Meurer, Roberto Giugliani, Fabiana Quoos Mayer, Angela Maria Vicente Tavares, Bárbara Zambiasi Martinelli, Talita Giacomet de Carvalho, Guilherme Baldo, Patricia Gnieslaw de Oliveira, Ursula da Silveira Matte, Fabíola Schons Meyer
Publikováno v:
Molecular Genetics and Metabolism. 105:S31